Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05927571
Title A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ISR | AUS

Facility Status City State Zip Country Details
The Alfred Hospital RECRUITING Prahan Victoria 3181 Australia Details
Rambam Health Care Campus RECRUITING Haifa 3109600 Israel Details
Sheba Medical Center - PPDS RECRUITING Ramat Gan 5266202 Israel Details
Tel Aviv Sourasky Medical Center PPDS RECRUITING Tel Aviv-Yafo 6423906 Israel Details
The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital) RECRUITING Seocho 06591 Korea, Republic of Details
Seoul National University Hospital RECRUITING Seoul 03080 Korea, Republic of Details
Samsung Medical Center - PPDS RECRUITING Seoul 06351 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field